Chengdu Olymvax Biopharmaceuticals Inc.

SHSE:688319 Stock Report

Market Cap: CN¥4.2b

Chengdu Olymvax Biopharmaceuticals Dividends and Buybacks

Dividend criteria checks 0/6

Chengdu Olymvax Biopharmaceuticals is a dividend paying company with a current yield of 0.37%.

Key information

0.4%

Dividend yield

-0.2%

Buyback Yield

Total Shareholder Yield0.2%
Future Dividend Yield1.3%
Dividend Growthn/a
Next dividend pay daten/a
Ex dividend daten/a
Dividend per shareCN¥0.038
Payout ratio-177%

Recent dividend and buyback updates

No updates

Recent updates

Chengdu Olymvax Biopharmaceuticals Inc. (SHSE:688319) Stock Rockets 40% As Investors Are Less Pessimistic Than Expected

Oct 09
Chengdu Olymvax Biopharmaceuticals Inc. (SHSE:688319) Stock Rockets 40% As Investors Are Less Pessimistic Than Expected

We Think Chengdu Olymvax Biopharmaceuticals (SHSE:688319) Has A Fair Chunk Of Debt

Sep 30
We Think Chengdu Olymvax Biopharmaceuticals (SHSE:688319) Has A Fair Chunk Of Debt

What Chengdu Olymvax Biopharmaceuticals Inc.'s (SHSE:688319) 26% Share Price Gain Is Not Telling You

Jun 24
What Chengdu Olymvax Biopharmaceuticals Inc.'s (SHSE:688319) 26% Share Price Gain Is Not Telling You

Is There An Opportunity With Chengdu Olymvax Biopharmaceuticals Inc.'s (SHSE:688319) 27% Undervaluation?

May 28
Is There An Opportunity With Chengdu Olymvax Biopharmaceuticals Inc.'s (SHSE:688319) 27% Undervaluation?

Chengdu Olymvax Biopharmaceuticals Inc. (SHSE:688319) Shares May Have Slumped 25% But Getting In Cheap Is Still Unlikely

Apr 18
Chengdu Olymvax Biopharmaceuticals Inc. (SHSE:688319) Shares May Have Slumped 25% But Getting In Cheap Is Still Unlikely

These 4 Measures Indicate That Chengdu Olymvax Biopharmaceuticals (SHSE:688319) Is Using Debt Extensively

Mar 26
These 4 Measures Indicate That Chengdu Olymvax Biopharmaceuticals (SHSE:688319) Is Using Debt Extensively

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Too early to tell whether 688319's dividend payments have been stable as they only just started paying a dividend.

Growing Dividend: Too early to tell if 688319's dividend payments are increasing as they only just started paying a dividend.


Dividend Yield vs Market

Chengdu Olymvax Biopharmaceuticals Dividend Yield vs Market
How does 688319 dividend yield compare to the market?
SegmentDividend Yield
Company (688319)0.4%
Market Bottom 25% (CN)0.6%
Market Top 25% (CN)2.2%
Industry Average (Biotechs)1.2%
Analyst forecast (688319) (up to 3 years)1.3%

Notable Dividend: 688319's dividend (0.37%) isn’t notable compared to the bottom 25% of dividend payers in the CN market (0.55%).

High Dividend: 688319's dividend (0.37%) is low compared to the top 25% of dividend payers in the CN market (2.17%).


Earnings Payout to Shareholders

Earnings Coverage: 688319 is paying a dividend but the company is unprofitable.


Cash Payout to Shareholders

Cash Flow Coverage: 688319 is paying a dividend but the company has no free cash flows.


Discover strong dividend paying companies